Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Public ClinicalTrials.gov record NCT06304883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-term Extension of a Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study of the Efficacy, Safety, and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to evaluate the long-term safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is an open-label trial of treatment with ALZ-801.
Study identification
- NCT ID
- NCT06304883
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2, 2024 (Actual)
- Primary completion
- Mar 11, 2026 (Actual)
- Completion
- Mar 11, 2026 (Actual)
- Last update posted
- Jun 25, 2026
2024 – 2026
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Xenoscience, Inc. | Phoenix | Arizona | 85004 | — |
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| ATP Clinical Research | Costa Mesa | California | 92626 | — |
| Torrance Clinical Research Institute | Lomita | California | 90717 | — |
| Sutter Health | Sacramento | California | 95816 | — |
| JEM Research Institute, Headlands Site | Atlantis | Florida | 33462 | — |
| K2 Medical Research, LLC | Maitland | Florida | 32751 | — |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Aqualane Clinical Research | Naples | Florida | 34105 | — |
| Charter Research | Orlando | Florida | 32803 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| ALZ Research and Treatment Center (A.R.T.C.) | Stuart | Florida | 34997 | — |
| ALZ Research and Treatment Center (A.R.T.C.) | Wellington | Florida | 33414 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Columbus Memory Center | Columbus | Georgia | 31909 | — |
| Fort Wayne Neurological Center | Fort Wayne | Indiana | 46804 | — |
| Headlands Research Eastern MA | Plymouth | Massachusetts | 02360 | — |
| Advanced Memory Research Center | Toms River | New Jersey | 08755 | — |
| Neurological Associates of Albany | Albany | New York | 12208 | — |
| NYU Alzheimer's Disease Research Center | New York | New York | 10016 | — |
| University of Rochester Medical Center | Rochester | New York | 14620 | — |
| Triad Clinical Trials | Greensboro | North Carolina | 27410 | — |
| AMC Research | Matthews | North Carolina | 28105 | — |
| Center for Cognitive Health | Portland | Oregon | 97225 | — |
| Abington Neurological Associates | Abington | Pennsylvania | 19001 | — |
| Rhode Island Mood & Memory Research Institute | East Providence | Rhode Island | 02914 | — |
| UT Health Science Center at Houston | Houston | Texas | 77054 | — |
| Re:Cognition Health | Fairfax | Virginia | 22031 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06304883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2026 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06304883 live on ClinicalTrials.gov.